These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 24176788

  • 1. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
    Baglietto-Vargas D, Kitazawa M, Le EJ, Estrada-Hernandez T, Rodriguez-Ortiz CJ, Medeiros R, Green KN, LaFerla FM.
    Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788
    [Abstract] [Full Text] [Related]

  • 2. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Feb; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 3. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM.
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [Abstract] [Full Text] [Related]

  • 4. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT, Wang ZJ, Cai HY, Yuan L, Hu MM, Wu MN, Qi JS.
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [Abstract] [Full Text] [Related]

  • 5. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T, Maekawa S, Kimura T, Takashima A, Tomiyama T, Mori H.
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [Abstract] [Full Text] [Related]

  • 6. Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease.
    Velazquez R, Shaw DM, Caccamo A, Oddo S.
    Mol Neurodegener; 2016 Jul 13; 11(1):52. PubMed ID: 27412291
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J, Lebbadi M, Tremblay C, St-Amour I, Pierrisnard C, Faucher-Genest A, Emond V, Julien C, Calon F.
    Synapse; 2018 Apr 13; 72(4):. PubMed ID: 29341269
    [Abstract] [Full Text] [Related]

  • 8. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL, Horne P, Yang J, Janus C, Bergeron C, Westaway D.
    Neurol Res; 2003 Sep 13; 25(6):590-600. PubMed ID: 14503012
    [Abstract] [Full Text] [Related]

  • 9. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH, Wu QY, Zheng R, Chen C, Chen Y, Liu Q, Hoffmann PR, Ni JZ, Song GL.
    J Neurosci; 2017 Mar 01; 37(9):2449-2462. PubMed ID: 28137967
    [Abstract] [Full Text] [Related]

  • 10. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R, Castello NA, Cheng D, Kitazawa M, Baglietto-Vargas D, Green KN, Esbenshade TA, Bitner RS, Decker MW, LaFerla FM.
    Am J Pathol; 2014 Feb 01; 184(2):520-9. PubMed ID: 24269557
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T.
    Alzheimers Res Ther; 2018 Jun 18; 10(1):54. PubMed ID: 29914551
    [Abstract] [Full Text] [Related]

  • 12. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL, Tung YC, Liu F, Gong CX, Iqbal K.
    Alzheimers Res Ther; 2017 Jan 10; 9(1):1. PubMed ID: 28073379
    [Abstract] [Full Text] [Related]

  • 13. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW, Ogino K, Shimabuku A, Taki T, Nakashima H, Ishihara T, Kitamoto T.
    Acta Neuropathol; 2007 Jun 10; 113(6):627-36. PubMed ID: 17431643
    [Abstract] [Full Text] [Related]

  • 14. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K.
    Neurobiol Dis; 2014 Nov 10; 71():110-30. PubMed ID: 25046994
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
    Qin X, Wang Y, Paudel HK.
    Am J Pathol; 2017 Aug 10; 187(8):1828-1847. PubMed ID: 28641077
    [Abstract] [Full Text] [Related]

  • 16. 3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation.
    Wang WZ, Li MW, Chen Y, Liu LY, Xu Y, Xia ZH, Yu Y, Wang XD, Chen W, Zhang F, Xu XY, Gao YF, Zhang JG, Qin SC, Wang H.
    J Alzheimers Dis; 2021 Aug 10; 82(4):1635-1649. PubMed ID: 34219730
    [Abstract] [Full Text] [Related]

  • 17. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J, Lee S, Kim J, Ham S, Park JHY, Han S, Jung YK, Shim I, Han JS, Lee KW, Kim J.
    Hum Mol Genet; 2020 Jan 15; 29(2):228-237. PubMed ID: 31814000
    [Abstract] [Full Text] [Related]

  • 18. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N, Toba J, Yoshii A, Nikkuni M, Ohshima T.
    J Neurosci Res; 2016 Jan 15; 94(1):15-26. PubMed ID: 26400044
    [Abstract] [Full Text] [Related]

  • 19. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
    Wang H, Liu X, Chen S, Ye K.
    Proc Natl Acad Sci U S A; 2018 Dec 26; 115(52):E12427-E12434. PubMed ID: 30530690
    [Abstract] [Full Text] [Related]

  • 20. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
    Vanden Dries V, Stygelbout V, Pierrot N, Yilmaz Z, Suain V, De Decker R, Buée L, Octave JN, Brion JP, Leroy K.
    Neurobiol Aging; 2017 Jul 26; 55():202-212. PubMed ID: 28464981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.